Mi-Ae Kim

Mi-Ae Kim

Auto-generated profile, based on publicly available information

Mi-Ae Kim

Division of Pulmonary Medicine, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2013 in International Journal of Industrial Entomology
Verified
Journal Article
Open access
HYHyung Joo Yoon
Hyung Joo Yoon
KLKyeong Yong Lee
Kyeong Yong Lee
MKMi Ae Kim
Mi Ae Kim
MAMi Young Ahn
Mi Young Ahn
IPIn Gyun Park
In Gyun Park

13 April 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
DJDa Som Jeon
Da Som Jeon
SKSeonok Kim
Seonok Kim
MKMi Ae Kim
Mi Ae Kim
YCYong Pil Chong
Yong Pil Chong
TSTae Sun Shim
Tae Sun Shim
KJKyung-Wook Jo
Kyung-Wook Jo
We assessed whether patients with T2DM are at higher risk for incident NTM disease through analysis of NTM-naive matched cohorts from the data of a national population-based cohort which represents 2.2% of the total South Korean population. Although T2DM alone is not a statistically significant risk factor for NTM disease, T2DM significantly increases the risk of NTM disease in those with ≥2 diabetes-related complications.

18 April 2020 in Antonie van Leeuwenhoek
Verified
Journal Article
Closed access
PDF file
JHJun Heo
Jun Heo
SKSoojin Kim
Soojin Kim
MKMi Ae Kim
Mi Ae Kim
TTTomohiko Tamura
Tomohiko Tamura
SSSatomi Saitou
Satomi Saitou
SKSoon-Wo Kwon
Soon-Wo Kwon

27 December 2024 in Medicine
Verified
Journal Article
Open access
TKTaehun Kim
Taehun Kim
SYSeong Hwan Youn
Seong Hwan Youn
MKMi-Ae Kim
Mi-Ae Kim
HKHyun Jung Kim
Hyun Jung Kim
YKYong Shik Kwon
Yong Shik Kwon
SPSun Hyo Park
Sun Hyo Park
Rationale: Lemierre syndrome is a rare, life-threatening complication of oropharyngeal infections. Patient concerns: A 35-year-old man started with an upper respiratory infection but worsened the clinical course with sepsis and acute respiratory failure with complicated bilateral pleural effusion. Diagnoses: The patient was diagnosed with typical Lemierre syndrome with lung complications. Interventions: Antibiotic therapy with bilateral pleural percutaneous drain with fibrinolysis. Outcomes: The patient improved and was discharged without oxygen therapy after antibiotics were covered and active lung care with complicated parapneumonic effusion. After discharge, lung function showed restrictive lung defect but improved compared to the initial exam. Lessons: Lemierre syndrome, which might begin as a mild upper respiratory infection, can progress to a critically ill disease accompanied by sepsis and metastatic septic embolus. The patient suffered septic lung emboli with bilateral complicated parapneumonic effusion but was successfully treated with percutaneous drainage with pleural fibrinolysis, appropriate antibiotics, and anticoagulants. Early suspicion of the disease and active treatment are necessary to treat rare syndromes like Lemierre syndrome.

22 September 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
MKMi-Ae Kim
Mi-Ae Kim
YPYea Eun Park
Yea Eun Park
YCYong Pil Chong
Yong Pil Chong
TSTae Sun Shim
Tae Sun Shim
KJKyung-Wook Jo
Kyung-Wook Jo
Kim MA, et al. J Korean Med Sci. 2022 Sep;37(40):e292. https://doi.org/10.3346/jkms.2022.37.e292

24 February 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TKTaehun Kim
Taehun Kim
MKMi-Ae Kim
Mi-Ae Kim
SYSeong Hwan Youn
Seong Hwan Youn
YKYongshik Kwon
Yongshik Kwon
HKHyun Jung Kim
Hyun Jung Kim
SPSun Hyo Park
Sun Hyo Park
Idiopathic pulmonary fibrosis (IPF) is characterised by progressive worsening of lung function. In some cases, IPF is accompanied by air-trapping and emphysema. This study aimed to evaluate air trapping quantified with RV/TLC in patients with IPF. This retrospective study included 122 patients diagnosed with IPF in South Korea between January 2011 and December 2020. Air trapping was defined as RV/TLC ≥ 0.40. Increased RV/TLC was found in 34.4% of all patients. The RV/TLC negatively correlated with lung function (forced expiratory volume in 1 s and functional vital capacity [FVC]) and showed consistent results after 1 year of follow-up. After propensity score matching, FVC and diffusion capacity between the groups showed no statistical difference. No difference in lung function decline was found between the increased and not increased RV/TLC groups. Regarding univariable analysis, the patients in the increased RV/TLC group had a lower risk of all-cause mortality (hazard ratio 1.753, P = 0.034). Using multivariable analysis, age, pirfenidone treatment, and FVC were significant factors for survival but not increased RV/TLC. Increased RV/TLC was related to emphysema and demonstrated a negative relationship with lung function. Although increased RV/TLC might relate to poor clinical outcome, it was not independent prognostic factor for IPF.